Watch our Webinar and discover IDT Biologika’s MVA technology platform and explore the advantages for development and manufacturing of multiple vaccines and cell and gene therapeutics. Learn more about
• What are IDT Biologika’s platform development principles?
• What are the benefits of our proprietary DF-1 platform for manufacturing rMVA-X vaccines?
• What are the special features of our innovative inhouse analytical methods.
